Back to mobile site

Rigel Pharmaceuticals (RIGL) Tops Q1 EPS by 44c

May 5, 2026 4:55 PM EDT

Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q1 EPS of $0.44. Revenue for the quarter came in at $58.8 million.

For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK